Community Health Network Investigational Drug Services — Indianapolis, Indiana

Community Health Network Investigational Drug Services is a clinical research site located in Indianapolis, Indiana, United States 46250.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Community Health Network Investigational Drug Services has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Community Health Network Investigational Drug Services?

Community Health Network Investigational Drug Services has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Community Health Network Investigational Drug Services conducted?

Community Health Network Investigational Drug Services has 1 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms.

Is Community Health Network Investigational Drug Services accredited by Crixeo Health?

Community Health Network Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Community Health Network Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.